Medipal Holdings Corporation (JP:7459)
:7459
7459 Stock Chart & Stats
¥2847.00
-¥35.00(-1.46%)
At close: 4:00 PM EST
¥2847.00
-¥35.00(-1.46%)
Day’s Range― - ―
52-Week Range¥2,156.00 - ¥3,070.00
Previous CloseN/A
Volume297.80K
Average Volume (3M)365.88K
Market Cap
¥533.63B
Enterprise Value¥371.37B
Total Cash (Recent Filing)¥246.03B
Total Debt (Recent Filing)¥38.85B
Price to Earnings (P/E)9.3
Beta0.52
Next Earnings
May 19, 2026EPS Estimate
44.65Next Dividend Ex-DateN/A
Dividend Yield2.27%
Share Statistics
EPS (TTM)74.68
Shares Outstanding215,975,040
10 Day Avg. Volume365,940
30 Day Avg. Volume365,883
Financial Highlights & Ratios
PEG Ratio-8.97
Price to Book (P/B)0.79
Price to Sales (P/S)0.13
P/FCF Ratio9.42
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)188.62
Revenue Forecast (FY)¥3.79T
Bulls Say, Bears Say
Bulls Say
Balance Sheet StrengthExtremely low leverage gives Medipal durable financial flexibility: it reduces interest burden, preserves borrowing capacity for acquisitions or capex, and improves resilience to reimbursement or volume shocks, supporting long-term stability and strategic optionality.
Cash GenerationA high free cash flow-to-net-income ratio indicates the business generates substantial cash relative to reported profits, enabling sustainable dividends, reinvestment in logistics and IT, and debt-light growth. This supports durable capital allocation over months to years.
Stable Revenue And MarginsConsistent revenue growth and stable gross margin reflect recurring wholesale demand and efficient procurement/logistics. Scale in distribution and long-term contracts with healthcare providers create predictable volumes and margin resilience across medium-term industry cycles.
Bears Say
Weak Cash Conversion (operating)Very low operating cash flow relative to net income suggests earnings are not being reliably converted to core cash, likely from working capital dynamics or timing differences. This can strain liquidity for inventories, capex, or consistent payouts over the medium term.
Thin ProfitabilityLow net and operating margins indicate limited pricing power and thin buffers against cost inflation or reimbursement pressure. Structural margin constraints reduce ability to absorb adverse volume or cost shocks and limit reinvestment capacity over multiple quarters.
Earnings DeteriorationNegative EPS growth of roughly -15% signals declining reported profitability, which may reflect margin pressure, cost creep, or one-off impacts. Continued EPS decline undermines retained earnings and could constrain funding for strategic investments and shareholder returns.
Medipal Holdings News
7459 FAQ
What was Medipal Holdings Corporation’s price range in the past 12 months?
Medipal Holdings Corporation lowest stock price was ¥2156.00 and its highest was ¥3070.00 in the past 12 months.
What is Medipal Holdings Corporation’s market cap?
Medipal Holdings Corporation’s market cap is ¥533.63B.
When is Medipal Holdings Corporation’s upcoming earnings report date?
Medipal Holdings Corporation’s upcoming earnings report date is May 19, 2026 which is in 50 days.
How were Medipal Holdings Corporation’s earnings last quarter?
Medipal Holdings Corporation released its earnings results on Feb 09, 2026. The company reported ¥74.68 earnings per share for the quarter, beating the consensus estimate of ¥50.37 by ¥24.31.
Is Medipal Holdings Corporation overvalued?
According to Wall Street analysts Medipal Holdings Corporation’s price is currently Overvalued.
Does Medipal Holdings Corporation pay dividends?
Medipal Holdings Corporation pays a Semiannually dividend of ¥32 which represents an annual dividend yield of 2.27%. See more information on Medipal Holdings Corporation dividends here
What is Medipal Holdings Corporation’s EPS estimate?
Medipal Holdings Corporation’s EPS estimate is 44.65.
How many shares outstanding does Medipal Holdings Corporation have?
Medipal Holdings Corporation has 215,975,040 shares outstanding.
What happened to Medipal Holdings Corporation’s price movement after its last earnings report?
Medipal Holdings Corporation reported an EPS of ¥74.68 in its last earnings report, beating expectations of ¥50.37. Following the earnings report the stock price went up 2.488%.
Which hedge fund is a major shareholder of Medipal Holdings Corporation?
Currently, no hedge funds are holding shares in JP:7459
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Medipal Holdings Corporation
Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprises medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is also involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; animal health products for companion animals; food processing raw materials for agriculture, fisheries, and livestock; and livestock feed additives, seasonings, veterinary medical equipment, packaging materials, industrial chemicals, and other products. In addition, it engages in the contract-based epidemiological studies, clinical studies, etc.; creation of a computerized medical supply database and master product databases for medical facilities; health insurance claims reviews, medical coding dispatch, outsourcing, and remote education activities; life and non-life insurance agency business; cleaning management; management and operation of distribution centers; commissioned delivery and worker dispatch business; and planning, management, administration, and product and service development for the class A health dispensing pharmacies service brand. Medipal Holdings Corporation serves hospitals, clinics, dispensing pharmacies, drugstores, home centers, convenience stores, supermarkets, discount stores, animal hospitals, livestock and fishery businesses, and processed food manufacturers. The company was formerly known as Mediceo Paltac Holdings Co., Ltd. and changed its name to Medipal Holdings Corporation in October 2009. Medipal Holdings Corporation was founded in 1898 and is headquartered in Tokyo, Japan.
Technical Analysis
Alfresa Holdings
―
Sundrug Co
―
Sugi Holdings Co
―
Suzuken Co
―
KUSURI NO AOKI HOLDINGS CO.,LTD.
―
Options Prices
Currently, No data available
---